Scholars@Duke publication: Molecular testing rarely changes the grade of meningiomas: The two-year experience at a single tertiary care center

Molecular testing rarely changes the grade of meningiomas: The two-year experience at a single tertiary care center

Publication , Conference

Chamberlin, G; Smith, V; Jones, K

Published in: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

2024

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

1554-6578

0022-3069

2024

445 / 446

APA

Chicago

ICMJE

MLA

NLM

Chamberlin, G., Smith, V., & Jones, K. (2024). Molecular testing rarely changes the grade of meningiomas: The two-year experience at a single tertiary care center. In JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (Vol. 83, pp. 445–446).

Chamberlin, G., V. Smith, and K. Jones. “Molecular testing rarely changes the grade of meningiomas: The two-year experience at a single tertiary care center.” In JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 83:445–46, 2024.

Chamberlin, G., et al. “Molecular testing rarely changes the grade of meningiomas: The two-year experience at a single tertiary care center.” JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, vol. 83, no. 6, 2024, pp. 445–46.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

1554-6578

0022-3069

2024

445 / 446